Figure 2. Analysis of CDR3 spectrums.
(A–D) A comparison of CDR3 region length and distribution between baseline and after 2 cycles of decitabine therapy in UPN1 (A), UPN2 (B), UPN3 (C), and UPN4 (D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.